瑞康医药

- 002589

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
瑞康医药(002589) 利润表
单位:万元
报表日期2020-12-312020-09-302020-06-302020-03-312019-12-31
一、营业总收入2,720,388.392,000,459.291,268,688.38576,363.773,525,850.95
营业收入2,720,388.392,000,459.291,268,688.38576,363.773,525,850.95
二、营业总成本2,625,957.131,916,391.171,216,890.70555,360.373,351,724.20
营业成本2,222,712.211,619,871.591,031,206.09470,497.682,843,937.10
营业税金及附加9,936.947,455.464,720.311,796.7314,194.57
销售费用217,490.72156,448.7293,795.2738,773.75264,917.61
管理费用116,603.0684,951.0954,811.0726,831.78145,305.64
财务费用58,322.8146,918.9431,855.9417,190.8082,672.18
研发费用891.39745.35502.03269.65697.11
资产减值损失----------
公允价值变动收益-8,701.692,785.11337.11-16,065.0017,469.22
投资收益22,680.938,484.137,991.4318,820.305,963.13
其中:对联营企业和合营企业的投资收益-2,693.62--------
汇兑收益----------
三、营业利润95,447.4790,553.6255,035.6519,744.3812,972.20
加:营业外收入1,555.331,349.24672.86200.051,545.85
减:营业外支出5,454.944,322.733,074.222,087.104,280.47
其中:非流动资产处置损失----------
四、利润总额91,547.8687,580.1352,634.3017,857.3310,237.57
减:所得税费用29,092.6824,348.6413,060.111,827.2653,735.57
五、净利润62,455.1863,231.4939,574.1916,030.07-43,497.99
归属于母公司所有者的净利润26,130.2730,871.9121,030.039,560.51-92,780.24
少数股东损益36,324.9132,359.5818,544.166,469.5549,282.25
六、每股收益
基本每股收益(元/股)0.21000.20500.14000.0600-0.6200
稀释每股收益(元/股)0.21000.20500.14000.0600-0.6200
七、其他综合收益----------
八、综合收益总额62,455.1863,231.4939,574.1916,030.07-43,497.99
归属于母公司所有者的综合收益总额26,130.2730,871.9121,030.039,560.51-92,780.24
归属于少数股东的综合收益总额36,324.9132,359.5818,544.166,469.5549,282.25
下载全部历史数据到excel中 返回页顶